The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:

General Notices

• Notice of Information: Request for Information (RFI) for Development of Vaccine Candidates for Biodefense, Antimicrobial Resistant (AMR) Infections, and Emerging Infectious Diseases, HHS-NIH-NIAID-BAA2024-1 Available in Sam.gov
  (NOT-AI-24-001)
  National Institute of Allergy and Infectious Diseases

• Notice of Information Regarding NIGMS' Expanded Program Eligibility for PA-23-189 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)"
  (NOT-GM-24-003)
  National Institute of General Medical Sciences

• Reminder: Annual Reports to the Office of Laboratory Animal Welfare due December 1, 2023
  (NOT-OD-24-008)
  Office of the Director, NIH

• Request for Information (RFI): National Heart Lung and Blood Institute (NHLBI) Strategic Vision Refresh
  (NOT-HL-23-118)
  National Heart, Lung, and Blood Institute

• Request for Information: Developing Consent Language for Research Using Digital Health Technologies
  (NOT-OD-24-002)
  Office of the Director, NIH
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  National Library of Medicine
  Office of Behavioral and Social Sciences Research

Notice of Changes to Funding Opportunities

• Notice of Change to NOT-AG-23-036, "Notice of Intent to Publish the Reissuance of RFA-AG-23-003"
  (NOT-AG-23-055)
  National Institute on Aging

• Notice of Change to RFA-AI-23-055, Research Tools for Difficult to Culture Eukaryotic Pathogens (R61/R33 Clinical Trial Not Allowed) to Include Frequently Asked Questions Information
  (NOT-AI-23-072)
  National Institute of Allergy and Infectious Diseases

• Notice of Change to section for PAR-23-194, "Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)"
  (NOT-DA-23-040)
  National Institute on Drug Abuse

• Notice of Change to Funding Opportunity Announcement, RFA-DC-24-001, BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Basic Experimental Studies with Humans Required)
  (NOT-DC-24-004)
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke

• Notice of additional Receipt Date for RFA-EY-23-001 BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
  (NOT-EY-24-001)
  National Eye Institute

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Centers of Excellence for Translational Research (CETR) (U19 Clinical Trial Not Allowed)
  (NOT-AI-23-071)
  National Institute of Allergy and Infectious Diseases

Notices of Special Interest

• Notice of Special Interest (NOSI): Advancing Genomic Medicine Research through Small Businesses
  (NOT-HG-24-002)
  National Human Genome Research Institute

Funding Opportunities

• Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed)
  (PAR-23-303)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  National Institute on Aging
  National Institute of Nursing Research
  Office of Research on Women's Health
• Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required)
  (PAR-23-304)
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  Office of Research on Women's Health
• Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (R24 Clinical Trials Not Allowed)
  (PAR-24-028)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  National Institute of General Medical Sciences
• Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
  (PAR-24-047)
  National Cancer Institute
• Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV and HBV (U19 Clinical Trial Not Allowed)
  (RFA-AI-23-057)
  National Institute of Allergy and Infectious Diseases
• Human Islet Research Network - Consortium on Modeling Autoimmune Diabetes (HIRN-CMAD) (UG3/UH3 Clinical Trial Not Allowed)
  (RFA-DK-23-004)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Allergy and Infectious Diseases
• Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (HBCUs) (UG3/UH3 Clinical Trial Not Allowed)
  (RFA-EB-23-006)
  National Institute of Biomedical Imaging and Bioengineering

Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 313-335-2123, or email Ann Ricketts or Lynn Hudachek.